Niagen Executives Buy 1M+ Zero‑Exercise Options: A Strong Insider Confidence Signal for Investors
Insider purchases of zero‑exercise Niagen Bioscience options reveal executive confidence and potential upside, paired with a promising NAD‑based pipeline and FDA Fast‑Track status.
3 minutes to read